The role of calcium and vitamin D in the management of osteoporosis.

Animals; Calcium/metabolism/therapeutic use; Dietary Supplements; Female; Humans; Osteoporosis/diet therapy/epidemiology; Postmenopause/drug effects; Vitamin D/pharmacology/therapeutic use

Abstract :

[en] The role of calcium and vitamin D supplementation in the treatment of osteoporosis has been extensively studied. The aim of this paper was to reach, where possible, consensus views on five key questions relating to calcium and vitamin D supplementation in the management of osteoporosis. Whereas global strategies that target supplementation to the general population could not be justified in terms of efficacy and health economics, there is a clearer rationale for supplementing patients who are at increased risk of osteoporosis and those who have developed osteoporosis, including those already taking other treatments for osteoporosis. The combination of vitamin D with calcium may be beneficial in terms of efficacy and, perhaps, for optimising adherence.

Disciplines :

General & internal medicine

Author, co-author :

Rizzoli, R.

Boonen, S.

Brandi, M. L.

Burlet, N.

Delmas, P.

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique

Language :

English

Title :

The role of calcium and vitamin D in the management of osteoporosis.

Publication date :

2008

Journal title :

BONE

ISSN :

8756-3282

eISSN :

1873-2763

Publisher :

Elsevier Science, New York, United States - New York

Volume :

Issue :

Pages :

246-9

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 28 August 2009

Statistics

Number of views

67 (2 by ULiège)

Number of downloads

3 (1 by ULiège)

More statistics

Scopus citations^®

110

Scopus citations^®
without self-citations

OpenCitations

104

OpenAlex citations

148

Bibliography

North American Menopause Society. The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause 3 (2006) 862-877
Winzenberg T., Shaw K., Fryer J., et al. Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials. BMJ 333 (2006) 775
Jackson R.D., LaCroix A., Gass M., et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354 (2006) 669-683
Prince R.L., Devine A., Dhaliwal S.S., et al. Effects of calcium supplementation on clinical fracture and bone structure. Arch Intern Med 166 (2006) 869-875
Porthouse J., Cockayne S., King C., et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330 (2005) 1003
Boonen S., Lips P., Bouillon R., et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 92 (2007) 1415-1423
Chapuy M.C., Pamphile R., Paris E., et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 13 (2002) 257-264
Sahota O., Mundey M.K., San P., et al. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35 (2004) 312-319
Dawson-Hughes B., Heaney R.P., Holick M.F., et al. Estimates of optimal vitamin D status. Osteoporos Int 16 (2005) 713-716
Bruyère O., Malaise O., Neuprez A., et al. European postmenopausal women have high prevalence of vitamin D inadequacy. Arthritis Rheum 54 Suppl S585 (2006)
Malabanan A., Veronikis I.E., and Holick M.F. Redefining vitamin D insufficiency. Lancet 351 (1998) 805-806
Chapuy M.C., Arlott M.E., Duboeuf F., et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327 (1992) 1637-1642
Dawson-Hughes B., Harris S.S., Krall E.A., et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337 (1997) 670-676
Larsen E.R., Mosekilde L., and Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents : a pragmatic population-based 3-year intervention study. J Bone Miner Res 19 (2004) 370-378
MacLaughlin J., and Holick M.F. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76 (1985) 1536-1538
Holick M.F., Matsuoka L.Y., Wortsman J., et al. Age, vitamin D, and solar ultraviolet. Lancet 2 (1989) 1104-1105
Ireland P., and Fordtran J.S. Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. J Clin Invest 52 (1973) 2672-2681
Bischoff-Ferrari H.A., Willett W.C., Wong J.B., et al. Fracture prevention with vitamin D supplementation. JAMA 293 (2005) 2257-2264
Heikinheimo R.J., Inkovaara J.A., Harju E.J., et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51 2 (1992) 105-110
Bischoff-Ferrari H.A. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 18 (2007) 401-407
RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of law-trauma fractures in elderly people (randomised evaluation of calcium or Vitamin D, record): a randomised placebo-controlled trial. Lancet 365 (2005) 1621-1628
Shea B., Wells G., Cranney A., et al. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocrine Reviews 23 (2002) 552-559
Avenell A., Gillespie W.J., Gillespie L.D., and O'Connell D.L. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 18 2 (2005) CD001880
Lips P., Graafmans W.C., Ooms M.E., et al. Vitamin D supplementation and fracture incidence in elderly persons. Ann Intern Med 124 (1996) 400-406
Meyer H.E., Smedshaug G.B., Kvaavik E., et al. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 17 (2002) 709-715
European Commission. Report on osteoporosis in the European Community - Action for prevention. Luxembourg: Office for official publications of the European Communities (1998)
Vieth E. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69 (1999) 842-856
Taylor R.L., Lynch H.J., and Wysor W.G. Seasonal influence of sunlight on the hypercalcemia of sarcoidosis. Am J Med 34 (1963) 221-227
Shai Florence, Baker R., Adrizzo J.R., et al. Hyperalcaemia in mycobacterial infection. J Clin Endocrinol 34 (1972) 251-256
Haussler M.R., and McCain T.A. Basic and clinical concepts related to vitamin D metabolism and action. N Engl J Med 297 (1977) 1041-1050
de Boer I.H., Ioannou G.N., Kestenbaum B., Brunzell J.D., and Weiss N.S. 25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 50 (2007) 69-77
Hsia J., Heiss G., Ren H., et al. Women's health initiative investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation 115 (2007) 846-854
Bone H.G., Hosking D., Devogelaer J.P., et al. Ten years experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350 (2004) 1189-1199
Neer R.M., Arnaud C.D., Zanchetta J.R., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344 (2001) 1434-1441
Harris S.T., Watts N.B., Genant H.K., et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 282 (1999) 1352
Ettinger B., Black D.M., Mitlak B.H., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA 282 (1999) 637-645
Chesnut C.H., Silverman S., Andriano K., et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 109 (2000) 267-276
Meunier P.J., Roux C., Seeman E., et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350 (2004) 459-468
Delmas P.D., Ensrud K.E., Adachi J.D., et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab 87 (2002) 3609-3617
Mastaglia S.R., Pellegrini G.G., Mandalunis P.M., et al. Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats. Bone 39 (2006) 837-844